Adoptive immunotherapy with autologous T cell infusions reduces opioid requirements in advanced cancer patients.
Sign Up to like & getrecommendations! Published in 2019 at "Pain"
DOI: 10.1097/j.pain.0000000000001702
Abstract: Relief of cancer-related pain remains challenging despite the availability of a range of opioid and non-opioid medications. Animal models demonstrate that T lymphocytes may mediate analgesia by producing endogenous opioids, but definitive clinical data are… read more here.
Keywords: immunotherapy autologous; cancer pain; adoptive immunotherapy; cancer ... See more keywords